Revance Therapeutics Inc (RVNC)

[Bio_pete]

I found this on off=label = "FDA is OK with the drug companies’ doing some indirect things, like responding to unsolicited requests for off-label information with truthful, balanced, non-misleading, and non-promotional scientific or medical information, or sponsoring educational programs or distributing medical journal articles in limited circumstances."

If a practitioner asks questions to the rep how other injectors are using the product then it wouldn't make sense for the FDA to have a problem with the rep guiding them on off-label use.